Cough variant asthma
Conditions
Interventions
Treatment group:Xianqi Qinglong formula granule
Control group:Placebo of Xianqi Qinglong formula granule plus flixotide
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Man and woman aged 18 to 75 years; 2. Course of cough more than 8 weeks, obviously irritating cough at night,cough as the clinical main symptoms or only symptom, no wheezing and fever; 3. The physical examination of the chest is normal; 4. Chest X-ray indicates basically normal; 5. Pulmonary function suggests that ventilation function is normal and bronchial provocation test is positive, or bronchial dilation test is positive; 6. Never use of inhaled corticosteroids and leukotriene receptor antagonist therapy; 7. TCM syndrome differentiation is wind-pathoge attacking the lung or deficiency of both the lung and kidney; 8. Patients have informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with COPD, bronchial dilation, interstitial lung disease, active tuberculosis and so on; 2. Taking additional ACEI drugs in the last 3 months; 3. Allergic to the treatment drugs; 4. Patients with serious heart, liver, kidney and blood system diseases; 5. Women during pregnant stage and breast-feed stage; 6. Psychiatric patients; 7. Patients are difficult to follow up; 8. Patients with a history of exposed to occupational dust, toxic and harmful gas.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom score of cough; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of days for cough relief;ECP;lung function;Score of syndrome curative effect;Evaluation of the quality of cough;Recurrence rate of cough; | — |
Countries
China
Contacts
Public ContactLin Lin
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed